REGENERON PHARMACEUTICALS, INC. Inventory
REGENERON PHARMACEUTICALS, INC. (REGN) had Inventory of $3.08 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-07-30
- 2026-06-30: Inventory, Net $3.08B.
- 2026-03-31: Inventory, Net $3.10B.
- 2025-12-31: Inventory, Net $3.20B.
- 2025-09-30: Inventory, Net $3.25B.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $3.08B 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $3.10B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $3.20B 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $3.25B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $3.21B 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $3.19B 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $3.09B 10-K · filed 2026-02-04 | |
| 2024-09-30 | $3.02B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $2.87B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $2.71B 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $2.58B 10-K · filed 2025-02-05 | |
| 2023-09-30 | $2.56B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $2.51B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $2.42B 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $2.40B 10-K · filed 2024-02-05 | |
| 2022-09-30 | $2.41B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $2.22B 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $1.99B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $1.95B 10-K · filed 2023-02-06 | |
| 2021-09-30 | $2.05B 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.98B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.16B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.92B 10-K · filed 2022-02-07 | |
| 2020-09-30 | $1.80B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.64B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.48B 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $1.42B 10-K · filed 2021-02-08 | |
| 2019-09-30 | $1.34B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.32B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.21B 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $1.15B 10-K · filed 2020-02-07 | |
| 2018-09-30 | $1.04B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $928.55M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $820.40M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $726.10M 10-K · filed 2019-02-07 | $726.14M 10-K · filed 2018-02-08 |
| 2017-09-30 | $641.59M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $554.32M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $466.58M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $399.36M 10-K · filed 2018-02-08 | |
| 2016-09-30 | $345.62M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $316.07M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $303.29M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $238.58M 10-K · filed 2017-02-09 | |
| 2015-09-30 | $190.67M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $171.27M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $133.86M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $128.86M 10-K · filed 2016-02-11 | |
| 2014-09-30 | $120.32M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $109.90M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $86.55M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $70.35M 10-K · filed 2015-02-12 | |
| 2013-09-30 | $63.29M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $57.16M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $43.98M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $28.64M 10-K · filed 2014-02-13 | |
| 2012-09-30 | $29.57M 10-Q · filed 2012-10-24 | |
| 2012-06-30 | $10.50M 10-Q · filed 2012-07-25 | |
| 2012-03-31 | $6.20M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $16.61M 10-K · filed 2013-02-15 | $3.50M 10-Q · filed 2012-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |